About

 MoJo biotechnology is a consulting partnership founded with the aim of helping guide biotechnology companies through the drug development process from discovery to late phase clinical.

We founded MoJo because we recognised that many smaller biotechnology companies don’t have the capacity to take on all of the various aspects of drug development and don’t know where to turn to get that help. Our aim is to work with your team to identify the critical activities and develop solutions that meet your timeline and budget.

• Early in discovery and need intermediates scaled up ? We can help find reliable sources 

• Need to identify a pre-clinical model service provider? We can help identify the most appropriate model, find a service provider and manage the interaction with your research provider.

• Ready for GLP Tox? We can help identify the provider, negotiate the scope of works and manage the process.

• Not sure what the next step is? We can help guide you through the process and answer such questions as do I need GMP material yet? How much stability data do I need at this stage? When should I characterise impurities?

• Trouble budgeting your entry to the clinic? We can help with budgeting and valuation modelling for your research program.

• Not sure how much Analytical validation you need for a certain stage? We can help align your analytical program with your development program.

• Looking for a cost effective API manufacturer in India or China but not sure who to trust? We have extensive experience over 15 years manufacturing around the world and can help guide the analysis of potential partners, and manage the process.

Our experience is derived from practical hands on development of products in human and animal health from conception to market. We have been involved in every step of the process.

As a registered Patent & Trade Marks Attorney in Australia and New Zealand, Michael is also able to help identify the experiments and programs needed to support your patent applications and structure your terms with service providers to protect your valuable IP.